Clinical Trial

Focal Laser Ablation in Prostate Cancer

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To assess the effectiveness of MRI-US or PSMA PET/CT-U/S fusion-guided focal laser ablation (FLA) for the treatment of a localized, intermediate-risk prostate cancer in terms of short-term oncological \& functional outcomes.
Trial Details
NCT Number NCT06916013
Lead Sponsor Ain Shams University
Conditions Prostate Cancer, Laser
Enrollment 30 participants
Start Date 2025-04-20
Primary Completion 2027-04-20 (estimated)
Study Completion 2027-08-20 (estimated)
Updated on ClinicalTrials.gov 2025-04-08